IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Item Statistics

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

RepositoryUniversity of Queensland [UQ eSpace]
URLhttps://espace.library.uq.edu.au/view/UQ:341600
Author(s)Cummins, K. D.; Jane, S. M.; Ninkovic, S.; Bazargan, A.; Filshie, R.; Sutrave, G.; Hertzberg, M.; Scott, A.; Lane, S.; Yannakou, C. K.; Ritchie, D.; D'Rozario, J.; Black, J.; Bavishi, K.; Wei, A.
Item typeArticle
JournalBlood Cancer Journal, Print_ISSN:2044-5385, Online_ISSN:2044-5385
DOIhttps://doi.org/10.1038/bcj.2014.59

Usage Date Range

Note: Daily statistics are only available for the last six weeks.

     

Country Reporting Period Total 2021-12-21
Overall totals 1 1
United States 1 1
Jisc logo Cranfield logo CAVAL logo